Arch Capital holder Halgan owns 304K shares
Initial Form 3 shows Jerome Halgan directly holding common shares and a series of vested and vesting stock options in ACGL.
Rhea-AI Filing Summary
ARCH CAPITAL GROUP LTD. (ACGL) reported the initial holdings of Jerome Halgan, who serves as CEO of Arch Global Reinsurance Group. He holds 304,627 Common Shares directly, along with multiple stock options to acquire additional common shares at exercise prices ranging from about $21.55 to $100.48 per share, with expirations extending from May 8, 2027 through March 3, 2036.
Positive
- None.
Negative
- None.
Insider Trade Summary
14 transactions reported
Mixed
14 txns
Insider
Halgan Jerome
Role
CEO, Arch Glob Reinsurance Grp
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (Right to Buy) F1 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F2 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F3 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F4 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F5 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F6 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F7 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F8 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F9 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F10 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F11 | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) F12 | -- | -- | -- |
| holding | Common Shares, $.0011 par value per share | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 135,703 contracts (Direct);
Common Shares, $.0011 par value per share — 304,627 shares (Direct)
Footnotes (12)
- F1. This stock option is exercisable in three equal annual installments commencing May 8, 2018, and the next two installments on May 8, 2019 and May 8, 2020, subject to the applicable award agreement.
- F2. This stock option is exercisable in three equal annual installments commencing December 28, 2018, and the next two installments on December 28, 2019 and December 28, 2020, subject to the applicable award agreement.
- F3. This stock option is exercisable in three equal annual installments commencing May 11, 2019, and the next two installments on May 11, 2020 and May 11, 2021, subject to the applicable award agreement.
- F4. This stock option is exercisable in three equal annual installments commencing February 28, 2020, and the next two installments on February 28, 2021 and February 28, 2022, subject to the applicable award agreement.
- F5. This stock option is exercisable in three equal annual installments commencing February 27, 2021, and the next two installments on February 27, 2022 and February 27, 2023, subject to the applicable award agreement.
- F6. This stock option is exercisable in three equal annual installments commencing February 26, 2022, and the next two installments on February 26, 2023 and February 26, 2024, subject to the applicable award agreement.
- F7. This stock option is exercisable in three equal annual installments commencing February 25, 2023, and the next two installments on February 25, 2024 and February 25, 2025, subject to the applicable award agreement.
- F8. This stock option is exercisable in three equal annual installments commencing February 24, 2024, and the next two installments on February 24, 2025 and February 24, 2026, subject to the applicable award agreement.
- F9. This stock option is exercisable in three equal annual installments commencing March 6, 2024, and the next two installments on March 6, 2025 and March 6, 2026, subject to the applicable award agreement
- F10. The stock option is exercisable in three equal annual installments commencing February 27, 2025, and the next two installments on February 27, 2026 and February 27, 2027, subject to the applicable award agreement
- F11. The stock option is exercisable in three equal annual installments commencing March 4, 2026, and the next two installments on March 4, 2027 and March 4, 2028, subject to the applicable award agreement.
- F12. This stock option is exercisable in three equal annual installments commencing March 3, 2027, and the next two installments on March 3, 2028 and March 3, 2029, subject to the applicable award agreement.
Key Figures
Directly held Common Shares: 304,627 shares
Stock option exercise price: $21.55 per share
Stock option exercise price: $37.42 per share
+4 more
7 metrics
Directly held Common Shares
304,627 shares
Common shares of ARCH CAPITAL GROUP LTD. held directly by Jerome Halgan as of September 3, 2026
Stock option exercise price
$21.55 per share
One option grant over 15,822 underlying common shares expiring May 11, 2028
Stock option exercise price
$37.42 per share
One option grant over 15,461 underlying common shares expiring February 27, 2030
Stock option exercise price
$64.17 per share
One option grant over 6,604 underlying common shares expiring February 24, 2033
Stock option exercise price
$82.22 per share
One option grant over 5,534 underlying common shares expiring February 27, 2034
Stock option exercise price
$92.48 per share
One option grant over 7,682 underlying common shares with exercise date May 2, 2028 and expiration May 2, 2035
Stock option exercise price
$100.48 per share
One option grant over 8,721 underlying common shares expiring March 3, 2036
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does ACGL’s Form 3 filing report for Jerome Halgan?
It reports Jerome Halgan’s initial beneficial ownership in ARCH CAPITAL GROUP LTD. (ACGL), including 304,627 Common Shares held directly and multiple stock options to purchase additional common shares at specified exercise prices and expiration dates.
What stock options in ACGL does Jerome Halgan hold according to this Form 3?
He holds several stock options over ACGL common shares, including options with exercise prices of $21.55, $27.67, $37.42, $64.17, $82.22, $92.48 and $100.48 per share, each covering specified share amounts and expiring between 2027 and 2036.
Do the options reported for Jerome Halgan in ACGL’s Form 3 have expiration dates?
Yes. The reported stock options expire on dates ranging from May 8, 2027 up to March 3, 2036, depending on the specific option grant.
Are any stock option vesting terms for ACGL disclosed for Jerome Halgan?
Yes. Footnotes state that several options become exercisable in three equal annual installments beginning on specified dates, such as May 8, 2018, February 24, 2024, February 27, 2025 and March 3, 2027, subject to the applicable award agreements.
Is there any stock option with a stated exercise date in Jerome Halgan’s ACGL Form 3?
Yes. One option with an exercise price of $92.48 per share has an exercise date of May 2, 2028 and an expiration date of May 2, 2035, covering 7,682 underlying common shares.
AI-generated analysis. How Rhea-AI works. Not financial advice.
